{"hq_id":"hq-p-spe-000094","name":"Surgical Mesh (Polypropylene Erosion, Chronic Pain, FDA Reclassification)","category":{"primary":"specialty","secondary":"medical","tags":["surgical mesh","polypropylene","hernia","pelvic","erosion","chronic pain","FDA"]},"product_tier":"SPE","overall_risk_level":"high","description":"Polypropylene surgical mesh for hernia repair and pelvic organ prolapse (POP) repair. FDA 2016: reclassified POP mesh from Class II to Class III (highest risk) after widespread adverse events — erosion, chronic pain, infection, organ perforation. FDA 2019: ordered manufacturers to stop selling POP mesh. Hernia mesh: remains Class II but 80,000+ lawsuits filed alleging chronic pain and complications. Mesh contraction, erosion into adjacent organs, and chronic inflammatory response are documented complications.","synthesis":{"derived_risk_level":"moderate_to_high","synthesis_confidence":0.5,"synthesis_method":"compound_composition","context_used":"human_adult","context_source":"product_users","exposure_modifier":1.4,"vulnerability_escalated":false,"escalation_reason":null,"compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-05-09","synthesis_version":"1.2.0","methodology_note":"exposure_modifier and adjusted_magnitude are computed from ALETHEIA-calibrated heuristics (route × duration × frequency multipliers, clamped to [0.5, 1.4]). Multipliers are directionally informed by EPA Exposure Factors Handbook (2011) and CalEPA OEHHA but are not regulatory consensus. See /api/methodology for full disclosure."},"hazard_summary":{"sensitive_populations":"all mesh recipients, especially POP mesh patients","overall_risk":"high","primary_concerns":["Mesh erosion into adjacent organs (vagina, bladder, bowel)","Chronic pain from mesh contraction and nerve entrapment","FDA reclassified POP mesh to Class III (highest risk) in 2016","FDA ordered stop sale of POP mesh in 2019","80,000+ lawsuits for hernia and pelvic mesh complications"],"exposure_routes":"Continuous exposure from permanently implanted polypropylene"},"exposure":{"routes":["dermal"],"contact_types":["skin_prolonged"],"users":["adult"],"duration":"continuous","frequency":"daily","scenarios":["Polypropylene mesh erosion into vaginal wall, bladder, or bowel","Chronic pain from mesh contraction and nerve entrapment","Inflammatory response to permanent foreign body","80,000+ lawsuits for hernia and pelvic mesh complications"],"notes":"FDA 2016: reclassified POP mesh to Class III. FDA 2019: ordered stop sale of POP mesh (manufacturers unable to demonstrate safety/efficacy superiority over native tissue repair). Hernia mesh: 80,000+ lawsuits (Johnson & Johnson, C.R. Bard, Atrium). Mesh complications may not present for years after implantation. Not all mesh is problematic — lightweight, large-pore mesh has lower complication rates."},"consumer_guidance":{"usage_warning":"For hernia repair: discuss mesh vs non-mesh options with surgeon. For POP: FDA ordered stop sale of transvaginal mesh — native tissue repair is now standard. If experiencing chronic pain, erosion symptoms, or recurrence after mesh surgery: consult mesh complication specialist. Document mesh product ID from surgical records.","safer_alternatives":["Lightweight, large-pore mesh for hernia (lower complication rate)","Native tissue repair for POP (FDA standard after 2019 order)","Biologic mesh alternatives for hernia (absorbable — lower permanent complication)","Non-mesh hernia repair techniques (Shouldice, Desarda)"],"red_flags":[{"indicator":"Health claims without FDA approval or clinical evidence","meaning":"Product efficacy unverified.","action":"Consult physician. Check FDA and clinical trial evidence."}],"green_flags":[{"indicator":"FDA-approved, USP-verified, or physician-recommended","meaning":"Verified safety and/or efficacy through established evaluation.","verification":"Check FDA approval status, USP mark, or published clinical evidence."}],"what_to_ask":[{"question":"Is there FDA-approved or peer-reviewed clinical evidence for this product?","why_it_matters":"Health products without evidence may be ineffective or harmful.","good_answer":"FDA-approved or supported by published RCTs.","bad_answer":"Testimonials only or DSHEA-exempt supplement with no clinical evidence."}],"alternatives":[{"name":"Lightweight, large-pore mesh for hernia","notes":"lower complication rate"},{"name":"Native tissue repair for POP","notes":"FDA standard after 2019 order"},{"name":"Biologic mesh alternatives for hernia","notes":"absorbable — lower permanent complication"}]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"FDA POP Mesh Reclassification (2016) and Stop Sale (2019)","citation":"FDA Order April 2019","requirements":"POP mesh reclassified to Class III (2016). FDA ordered stop sale of POP mesh (2019) — manufacturers could not demonstrate superiority over native tissue repair. Hernia mesh remains Class II.","compliance_status":null,"effective_date":"2019-04-16","enforcing_agency":"FDA","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":false,"disposal_guidance":"Explanted mesh: medical waste.","hazardous_waste":false,"expected_lifespan":"permanent"},"formulation":{"form":"varies","key_ingredients":[{"hq_id":"hq-c-mix-000064","name":"Polypropylene microplastics (PP-MP)","role":"mesh_material","concentration_pct":"100"}],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-mix-000064","compound_name":null,"role":"mesh_material","typical_concentration":"100%"}],"identifiers":{"common_names":["surgical mesh (polypropylene erosion, chronic pain, fda reclassification)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"3M","manufacturer":"3M","market_position":"mass_market","notable":"Safety and specialty product conglomerate"},{"brand":"Honeywell","manufacturer":"Honeywell","market_position":"mass_market","notable":"Safety equipment and technology"},{"brand":"DuPont","manufacturer":"DuPont","market_position":"professional","notable":"Chemical and safety products"}],"brand_examples_disclaimer":"Representative branded products of this category. Concerning ingredients listed in materials.concerning[] apply to the category, not necessarily to every named brand. Specific formulations vary by SKU and may have changed since this record was written; consult the brand's current ingredient label before drawing brand-level conclusions.","sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-25"},{"type":"regulation","title":"FDA POP Mesh Reclassification (2016) and Stop Sale (2019) (FDA Order April 2019)","jurisdiction":"USA","year":2019,"citation":"FDA Order April 2019","id":"src_fcd679eb"},{"type":"regulatory","title":"US Food and Drug Administration (FDA)","jurisdiction":"USA","id":"src_82d1cfcd","extraction":"description_reference"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-14T01:24:28.131Z"}}